Vilacto Bio (VIBI) 10-Q2019 Q1 Quarterly report

Filed: 20 Aug 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accreted, Adar, Additionally, agency, aggregate, amended, Amortization, amortized, arising, bid, bifurcate, brand, bring, buyer, calendar, cancer, charge, charged, component, contract, conversion, convert, converted, convertible, cured, currency, deducting, default, Delaware, delivery, derivative, disclosed, document, drug, Eagle, EMA, embedded, emerging, entitled, event, favorable, FDA, feature, foreign, gain, GS, guidance, hedge, hedging, host, iii, immunodeficiency, iTHER, iv, January, judgment, lender, lesser, LLC, lowest, made, mature, minimal, model, nanoparticle, nature, option, permit, permitted, potent, premium, prepay, principal, promised, proven, reduction, register, Registration, remain, resale, research, revalued, significantly, SPA, stage, stream, substance, system, table, thrombocytopenia, uncertainty, unchanged, unpaid, unrealized, utilized, variant, Vilact, vitiligo

Removed: acquire, acquisition, allocated, Andersen, appointed, assignment, assumed, assured, borrowed, Bulletin, commence, conclusion, controlling, Dana, director, earmarked, evidence, fourth, Gallovicova, identifiable, indefinite, investor, lack, lived, online, paid, participant, performed, perspective, persuasive, preliminary, qualitative, ramp, record, recoverable, release, resigned, Secretary, service, tangible, transfer, Treasurer, unpredictable

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

VIBI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly Report of Vilacto Bio, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2018 filed with the Securities and Exchange Commission (the “Report”), I, Gert Andersen, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

By:	/s/ Gert Andersen
Name:	Gert Andersen
Title:	Principal Executive Officer, Principal Financial Officer and Director
Date:A	August 20, 2018

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.